| name | Beclomethasone Formoterol |
| Classification | Combination inhaler; inhaled corticosteroid and long-acting beta2-agonist for the treatment of asthma and COPD. |
| Pharmacokinetics | Beclomethasone is a potent inhaled corticosteroid that primarily acts locally in the lungs, minimizing systemic effects. Formoterol is a long-acting beta2-agonist, providing bronchodilation. The pharmacokinetics of each component are largely unaffected by combination. Absorption, distribution, metabolism, and excretion patterns are complex and may vary between individuals based on factors such as lung disease severity, dose, and route of administration. |
| suggested dosage | Dosage should be determined by a healthcare professional based on individual patient needs and response to treatment. Adjustments may be needed over time. Typical starting doses are lower, and doses gradually increased to optimal levels. Specific doses depend on the particular brand and formulation (e.g., 100/5, 200/10 micrograms) and often vary between asthma and COPD patients. |
| indications | | 1 | Treatment of asthma, including prevention of asthma exacerbations | | 2 | Treatment of chronic obstructive pulmonary disease (COPD) in patients who require long-term bronchodilation and inhaled corticosteroids |
|
| Safety in pregnancy | Limited data. Inhaled corticosteroids should be used during pregnancy only when the potential benefit justifies the potential risk to the fetus. Consult with a healthcare provider regarding potential risks and benefits. |
| Safety in breastfeeding | Limited data. Inhaled corticosteroids may be present in breast milk; however, the risk to the infant is likely to be low at recommended doses. Consult with a healthcare provider regarding potential risks and benefits. |
| side effects | | 1 | Cough | | 2 | Oral candidiasis (thrush) | | 3 | Hoarseness | | 4 | Headache | | 5 | Tremor | | 6 | Palpitations | | 7 | Changes in heart rate | | 8 | Muscle aches | | 9 | Nausea | | 10 | Insomnia | | 11 | Anxiety | | 12 | Systemic effects (rare): Changes in blood sugar, increased risk of osteoporosis (especially with long-term use) |
|
| alternatives | |
| contraindications | | 1 | Hypersensitivity to beclomethasone, formoterol, or any of the excipients | | 2 | Severe uncontrolled cardiac arrhythmias | | 3 | Uncontrolled heart failure |
|
| interactions | Many medications can interact with inhaled corticosteroids and long-acting beta2-agonists. Inform your doctor about all medications you are taking. There may be interactions with other inhalers, oral medications, and certain herbal supplements. |
| warnings and precautions | | 1 | Regular monitoring of lung function is essential. | | 2 | Patients should be instructed on proper inhaler technique to maximize drug delivery and minimize side effects. | | 3 | Advise patients to monitor for signs of infection in their mouth (oral thrush) | | 4 | If side effects occur or worsen, consult with your healthcare provider. |
|
| additional information | Patients with a history of other respiratory conditions should inform their physician. Follow all instructions from your doctor carefully. |
| patient specific notes | A 25-year-old male weighing 70 kg is a typical patient population for this medication. However, a physician must tailor the dose and treatment plan based on individual factors and ongoing evaluation. A thorough assessment of the patient's asthma or COPD severity is required. |
